January 12, 2001

2 min read

Google Logo Add Us On GoogleAdd SciAm

New Protein Blocks HIV

By Kate Wong

Join Our Community of Science Lovers!

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

Researchers have designed a protein that can inhibit HIV infection by blocking the virus's entry into cells. This protective protein, known as 5-Helix, binds to a vulnerable region of an HIV coat protein called gp41, thus preventing the virus from fusing with membrane of the cell it is attacking and infecting it. What's more, 5-Helix appears to effectively thwart a wide range of HIV strains. As such, it may serve as the basis for developing a new class of anti-HIV drugs. Alternatively it could be used in prophylactic treatments (say, after an accidental needle prick in a hospital), or perhaps as a vaccine. A team led by Peter S. Kim of the Whitehead Institute for Biomedical Research describe their discovery in a report that appears today in Science.

Kim and his colleagues have been investigating gp41 for years, knowing that this HIV protein plays a critical role in enabling the virus to fuse its membrane with that of its target cell. With that in mind, they fashioned 5-Helix, which binds to specifically and tightly to gp41. Another so-called entry inhibitor, T-20, showed promise, but large quantities were required to achieve positive results in patients. 5-Helix, in contrast, seems effective even in low concentrations. The new protein may even pave the way to combating other viruses like Ebola, human respiratory syncytial virus (HRSV) and the flu--all of which employ a fusion strategy similar to that of HIV.

Having determined that 5-Helix inhibits HIV in cell culture, researchers must now ascertain whether it works in an animal model. If so, they could then begin to develop it for humans. "Current therapy is working," Kim observes, "but sexual transmission of virus that is resistant to treatment has been documented, making it important to continue to find new targets and therapies for stopping HIV."

Kate Wong is an award-winning science writer and senior editor for features at Scientific American, where she has focused on evolution, ecology, anthropology, archaeology, paleontology and animal behavior. She is fascinated by human origins, which she has covered for nearly 30 years. Recently she has become obsessed with birds. Her reporting has taken her to caves in France and Croatia that Neandertals once called home to the shores of Kenya’s Lake Turkana in search of the oldest stone tools in the world, as well as to Madagascar on an expedition to unearth ancient mammals and dinosaurs, the icy waters of Antarctica, where humpback whales feast on krill, and a “Big Day” race around the state of Connecticut to find as many bird species as possible in 24 hours. Wong is co-author, with Donald Johanson, of Lucy’s Legacy: The Quest for Human Origins. She holds a bachelor of science degree in biological anthropology and zoology from the University of Michigan. Follow her on Bluesky @katewong.bsky.social

More by Kate Wong

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe